Numan

UK digital health platform for men's health — ED, hair loss, weight loss, and (newly) women's hormonal health.

Healthcare 📍 London, United Kingdom Founded 2018

Current Valuation

Private

as of 2025-Q3

PRIVATE

Numan is a UK-based digital health platform that started in men's health (ED, hair loss, testosterone) and rapidly expanded into weight loss (riding the GLP-1 wave) and women's hormonal health. Revenue more than doubled to over $90M in 2024 on the back of weight-loss drug demand; the company raised $60M in 2025 to fuel the women's-health expansion.

Company Profile

CEO

Sokratis Papafloratos

Founded

2018

London, United Kingdom

Employees

~200

Total Raised

$150M

Est. Revenue

$90M (2024-Q4)

Growth

~141% YoY

Last Round

Series C — $60M (Jul 2025) · Lead: White Star Capital

IPO Status

private

Founders & Key People

Sokratis Papafloratos

Investors

White Star Capital · Vorwerk Ventures · Hambro Perks · Novator Ventures

Products

Numan Men's Health
Numan Weight Loss (GLP-1)
Numan Hair Loss
Numan Women (hormonal health)

Competitors

Hims & Hers · Manual · Ro Health · Lemonaid

telehealthmens-healthglp-1uk-startupdigital-health